Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Capital Expenditures (2016 - 2022)

Nephros (NEPH) has 6 years of Capital Expenditures data on record, last reported at $103000.0 in Q2 2022.

  • For Q2 2022, Capital Expenditures changed N/A year-over-year to $103000.0; the TTM value through Sep 2024 reached $103000.0, changed N/A, while the annual FY2024 figure was $55000.0, 26.67% down from the prior year.
  • Capital Expenditures reached $103000.0 in Q2 2022 per NEPH's latest filing, up from $34000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $103000.0 in Q2 2022 and bottomed at $13000.0 in Q3 2020.
  • Average Capital Expenditures over 3 years is $37200.0, with a median of $23000.0 recorded in 2021.
  • Peak YoY movement for Capital Expenditures: changed 0.0% in 2021, then surged 47.83% in 2022.
  • A 3-year view of Capital Expenditures shows it stood at $13000.0 in 2020, then changed by 0.0% to $13000.0 in 2021, then soared by 692.31% to $103000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $103000.0 in Q2 2022, $34000.0 in Q1 2022, and $13000.0 in Q3 2021.